{"date":"2026-04-16","count":22,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2026-04-16-2040-xpdg90","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-04-16","time":"20:40:41","subject":"公告本公司董事會決議召開115年股東常會(變更開會地點及新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-04-16 20:40，「公告本公司董事會決議召開115年股東常會(變更開會地點及新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1781-2026-04-16-1747-7qgulw","company_id":"1781","company":"合世","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"17:47:13","subject":"公告本公司董事會決議召開115年股東常會(更正股東會召集事由)","clause":"第17款","fact_date":"2026-04-16","cite_as":"公開資訊觀測站重大訊息：合世（1781），2026-04-16 17:47，「公告本公司董事會決議召開115年股東常會(更正股東會召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-04-16-1733-3poh2l","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"17:33:20","subject":"代重要子公司康儀科技股份有限公司公告分派股利","clause":"第31款","fact_date":"2026-04-16","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-04-16 17:33，「代重要子公司康儀科技股份有限公司公告分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-04-16-1731-fx98nb","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"17:31:52","subject":"代重要子公司康儀科技股份有限公司公告單一法人董事代行股東會之重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-04-16 17:31，「代重要子公司康儀科技股份有限公司公告單一法人董事代行股東會之重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-04-16-1729-15a2239","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"17:29:40","subject":"補充公告本公司董事會決議召開115年股東常會相關事宜(增列議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-04-16 17:29，「補充公告本公司董事會決議召開115年股東常會相關事宜(增列議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-04-16-1727-92x690","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"17:27:43","subject":"董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-04-16 17:27，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-04-16-1703-9756bm","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"17:03:17","subject":"公告更正本公司115年股東常會相關事宜(更正原因:本次會議無討論事項之召集事由，欄位無須點選誤植\"無\"。)","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-04-16 17:03，「公告更正本公司115年股東常會相關事宜(更正原因:本次會議無討論事項之召集事由，欄位無須點選誤植\"無\"。)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-04-16-1659-1wveksb","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"16:59:43","subject":"公告董事會決議召開115年股東常會相關事宜(新增討論案)","clause":"第32款","fact_date":"2026-04-16","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-04-16 16:59，「公告董事會決議召開115年股東常會相關事宜(新增討論案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-04-16-1657-2qf30l","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"16:57:38","subject":"本公司董事會決議辦理私募普通股或私募國內可轉換公司債","clause":"第9款","fact_date":"2026-04-16","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-04-16 16:57，「本公司董事會決議辦理私募普通股或私募國內可轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-04-16-1656-1rkffgt","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"16:56:52","subject":"公告本公司董事會追認修訂115年度第一次員工認股權憑證發行及認股辦法","clause":"第9款","fact_date":"2026-04-16","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-04-16 16:56，「公告本公司董事會追認修訂115年度第一次員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-04-16-1650-xgopbq","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"16:50:01","subject":"公告本公司高肝腎安全性乙醯胺酚止痛新藥SNP-810(安泰拿疼)取得墨西哥專利","clause":"第44款","fact_date":"2026-04-16","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-04-16 16:50，「公告本公司高肝腎安全性乙醯胺酚止痛新藥SNP-810(安泰拿疼)取得墨西哥專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-04-16-1634-fn5aok","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"16:34:17","subject":"本公司受邀參加富邦證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-04-16 16:34，「本公司受邀參加富邦證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-04-16-1633-10jca0t","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"16:33:28","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-04-16 16:33，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-04-16-1606-1g0px2","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-04-16","time":"16:06:55","subject":"公告本公司訂定115年現金增資認股基準日及相關事宜(補充代收款及存儲專戶行庫)。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-04-16 16:06，「公告本公司訂定115年現金增資認股基準日及相關事宜(補充代收款及存儲專戶行庫)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-04-16-1606-gi3647","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"16:06:26","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-04-16 16:06，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-04-16-1512-1yvi7ml","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"15:12:00","subject":"公告本公司董事會授權董事長訂定除權基準日相關事宜","clause":"第14款","fact_date":"2026-04-16","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-04-16 15:12，「公告本公司董事會授權董事長訂定除權基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-04-16-1511-4ej9az","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"15:11:31","subject":"公告本公司董事會決議限制員工權利新股收回註銷暨訂定減資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-04-16 15:11，「公告本公司董事會決議限制員工權利新股收回註銷暨訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-04-16-1510-1jb8ii5","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"15:10:59","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-04-16 15:10，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-04-16-1411-1tdnhwx","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-04-16","time":"14:11:16","subject":"本公司上市掛牌首五個營業日穩定價格操作結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-04-16 14:11，「本公司上市掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-04-16-1400-1hm4i67","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"14:00:26","subject":"代美國子公司Tulex Pharmaceuticals公告,TLX-042新藥(505(b)(2))液態口服癲癇藥物已向美國FDA提出新藥查驗登記申請(NDA)","clause":"第10款","fact_date":"2026-04-16","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-04-16 14:00，「代美國子公司Tulex Pharmaceuticals公告,TLX-042新藥(505(b)(2))液態口服癲癇藥物已向」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-04-16-1311-1ec8urp","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-04-16","time":"13:11:06","subject":"澄清115年4月16日財訊快報報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-04-16 13:11，「澄清115年4月16日財訊快報報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-04-16-0953-14vxids","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-04-16","time":"09:53:10","subject":"(補充115/3/10公告)本公司董事會決議通過投資有價證券","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-04-16 09:53，「(補充115/3/10公告)本公司董事會決議通過投資有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}